Filing Details

Accession Number:
0001209191-13-016023
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-12 18:33:56
Reporting Period:
2013-03-08
Filing Date:
2013-03-12
Accepted Time:
2013-03-12 18:33:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1000228 Henry Schein Inc HSIC Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047) 113136595
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1194352 E Mark Mlotek C/O Henry Schein, Inc.
135 Duryea Road
Melville NY 11747
Evp, Chief Strategic Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.01 Per Share Acquisiton 2013-03-08 3,932 $0.00 72,705 No 4 A Direct
Common Stock, Par Value $0.01 Per Share Disposition 2013-03-08 7,970 $90.32 64,735 No 4 F Direct
Common Stock, Par Value $0.01 Per Share Disposition 2013-03-08 1,451 $90.16 63,284 No 4 S Direct
Common Stock, Par Value $0.01 Per Share Disposition 2013-03-11 9,110 $89.43 54,174 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Par Value $0.01 Per Share 800 Indirect By children
Common Stock, Par Value $0.01 Per Share 2,053 Indirect By 401(k) plan
Footnotes
  1. Represents additional shares of the issuer's common stock issued under the Henry Schein, Inc. 1994 Stock Incentive Plan that vested on March 8, 2013 in connection with exceeding the performance target with respect to the reporting person's March 10, 2010 grant of performance-based restricted stock. (Actual vesting date of March 10, 2013 was a non-business day so vesting occurred on the preceding business day.)
  2. Represents the surrender of shares to the issuer to satisfy the reporting person's tax withholding obligation upon the vesting of the reporting person's March 9, 2009 grant of time-based restricted stock and March 10, 2010 grant of performance-based restricted stock, each of which vested on March 8, 2013. (Actual vesting dates were non-business days so vesting occurred on the preceding business day.)
  3. The price reflects a weighted average of sales made at prices ranging from $90.16 to $90.17 per share. The Reporting Person, upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, will provide full information regarding the number of shares sold at each separate price for this transaction.